Potency of a vaccine prepared from A/swine/Hokkaido/2/1981 (H1N1) against A/Narita/1/2009 (H1N1) pandemic influenza virus strain

Virology Journal

Volumn 10, Issue , 2013, Pages

  Okamatsu, Masatoshi ^a   Sakoda, Yoshihiro ^a   Hiono, Takahiro ^a   Yamamoto, Naoki ^a   Kida, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Influenza A (H1N1)pdm; Swine influenza virus; Vaccine

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG POTENCY; FEMALE; IMMUNE RESPONSE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC INFLUENZA; VIROGENESIS; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; DISEASE MODELS, ANIMAL; EMERGENCY TREATMENT; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INJECTIONS, SUBCUTANEOUS; MICE; ORTHOMYXOVIRIDAE INFECTIONS; SWINE;

AVES; MUS; ORTHOMYXOVIRIDAE; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 84873270679     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-47     Document Type: Article

References (32)

1. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM, N Engl J Med 2009 360 2605 2615 19423869
2. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Science 2009 325 197 201 10.1126/science.1176225 19465683
3. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, et al. Nature 2009 459 1122 1125 10.1038/nature08182 19516283
4. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. N Engl J Med 2009 361 1945 1952 10.1056/NEJMoa0906453 19745214
5. Response to a monovalent 2009 influenza A (H1N1) vaccine. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL, N Engl J Med 2009 361 2405 2413 10.1056/NEJMoa0907413 19745216
6. Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Wanitchang A, Kramyu J, Jongkaewwattana A, Virus Res 2010 147 145 148 10.1016/j.virusres.2009.10.010 19879908
7. Molecular evidence for a role of domestic ducks in the introduction of avian H3 influenza viruses to pigs in southern China, where the A/Hong Kong/68 (H3N2) strain emerged. Yasuda J, Shortridge KF, Shimizu Y, Kida H, J Gen Virol 1991 72 Pt 8 2007 2010 1875195
8. Potential for transmission of avian influenza viruses to pigs. Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, Kawaoka Y, Webster RG, J Gen Virol 1994 75 Pt 9 2183 2188 8077918 (Pubitemid 24282230)
9. Origin of the hemagglutinin gene of H3N2 influenza viruses from pigs in China. Kida H, Shortridge KF, Webster RG, Virology 1988 162 160 166 10.1016/0042-6822(88)90405-9 3336940
10. Antigenic and genetic conservation of H3 influenza virus in wild ducks. Kida H, Kawaoka Y, Naeve CW, Webster RG, Virology 1987 159 109 119 10.1016/0042-6822(87)90353-9 2440178
11. Isolation and characterization of influenza a viruses from wild free-flying ducks in Hokkaido, Japan. Kida H, Yanagawa R, Zentralbl Bakteriol Orig A 1979 244 135 143 506542 (Pubitemid 9247218)
12. Precursor genes of future pandemic influenza viruses are perpetuated in ducks nesting in Siberia. Okazaki K, Takada A, Ito T, Imai M, Takakuwa H, Hatta M, Ozaki H, Tanizaki T, Nagano T, Ninomiya A, et al. Arch Virol 2000 145 885 893 10.1007/s007050050681 10881676 (Pubitemid 30332608)
13. Phylogenic analysis of the M genes of influenza viruses isolated from free-flying water birds from their Northern Territory to Hokkaido, Japan. Manzoor R, Sakoda Y, Mweene A, Tsuda Y, Kishida N, Bai GR, Kameyama K, Isoda N, Soda K, Naito M, Kida H, Virus Genes 2008 37 144 152 10.1007/s11262-008-0248-7 18612806
14. Ecology of influenza viruses in nature, birds, and humans. Kida H, Global Environmental Research 2008 12 9 14
15. Library of influenza virus strains for vaccine and diagnostic use against highly pathogenic avian influenza and human pandemics. Kida H, Sakoda Y, Dev Biol (Basel) 2006 124 69 72 (Pubitemid 43258901)
16. The annual production cycle for influenza vaccine. Gerdil C, Vaccine 2003 21 1776 1779 10.1016/S0264-410X(03)00071-9 12686093 (Pubitemid 36398372)
17. Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs. Lu B, Zhou H, Chan W, Kemble G, Jin H, Vaccine 2006 24 6691 6693 10.1016/j.vaccine.2006.05.062 16814431 (Pubitemid 46107169)
18. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. Kodihalli S, Justewicz DM, Gubareva LV, Webster RG, J Virol 1995 69 4888 4897 7609057
19. Evolution and ecology of influenza A viruses. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y, Microbiol Rev 1992 56 152 179 1579108
20. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. Hovden AO, Cox RJ, Haaheim LR, Scand J Immunol 2005 62 36 44 16092921 (Pubitemid 41025876)
21. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Hagenaars N, Mastrobattista E, Glansbeek H, Heldens J, van den Bosch H, Schijns V, Betbeder D, Vromans H, Jiskoot W, Vaccine 2008 26 6555 6563 10.1016/j.vaccine.2008.09.057 18848856
22. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ, Sci Transl Med 2010 2 25ra24 10.1126/scitranslmed.3000759 20424013
23. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H, Vaccine 2008 26 562 572 10.1016/j.vaccine.2007.11.031 18164788
24. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, et al. Arch Virol 2008 153 1685 1692 10.1007/s00705-008-0171-1 18651092
25. Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic. Takada A, Kuboki N, Okazaki K, Ninomiya A, Tanaka H, Ozaki H, Itamura S, Nishimura H, Enami M, Tashiro M, et al. J Virol 1999 73 8303 8307 10482580 (Pubitemid 29441691)
26. A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens. Sakabe S, Sakoda Y, Haraguchi Y, Isoda N, Soda K, Takakuwa H, Saijo K, Sawata A, Kume K, Hagiwara J, et al. Vaccine 2008 26 2127 2134 18346824
27. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines. Kashima Y, Ikeda M, Itoh Y, Sakoda Y, Nagata T, Miyake T, Soda K, Ozaki H, Nakayama M, Shibuya H, et al. Vaccine 2009 27 7402 7408 10.1016/j.vaccine.2009.08.089 19747993
28. Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques. Itoh Y, Ozaki H, Ishigaki H, Sakoda Y, Nagata T, Soda K, Isoda N, Miyake T, Ishida H, Okamoto K, et al. Vaccine 2010 28 780 789 10.1016/j.vaccine.2009.10.067 19857455
29. PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs. Manzoor R, Sakoda Y, Nomura N, Tsuda Y, Ozaki H, Okamatsu M, Kida H, J Virol 2009 83 1572 1578 10.1128/JVI.01879-08 19052090
30. Application of a microtechnique to viral serological investigations. Sever JL, J Immunol 1962 88 320 329 13910995
31. Antigenic and genetic analysis of H5 influenza viruses isolated from water birds for the purpose of vaccine use. Soda K, Ozaki H, Sakoda Y, Isoda N, Haraguchi Y, Sakabe S, Kuboki N, Kishida N, Takada A, Kida H, Arch Virol 2008 153 2041 2048 10.1007/s00705-008-0226-3 18932020
32. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Kida H, Brown LE, Webster RG, Virology 1982 122 38 47 10.1016/0042-6822(82)90375-0 6182687 (Pubitemid 12004497)